Skip to content

Effectiveness of Electro-Acupuncture on treating MDD: a Randomized Controlled Trial

Effectiveness of Electro-Acupuncture on treating MDD": a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003083
Enrollment
Unknown
Registered
2020-03-05
Start date
2020-03-16
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Sponsors

Shanghai Seventh People's Hospital, Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with MDD who meet the following criteria will be included: 1. Between 18 and 75 years of age with no gender-based restriction; 2. Fulfilling the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM V) for major depressive disorder; 3. A Hamilton Rating Scale for Depression (HDRS-17) score with a range between 17 to 24 (24 > HDRS-17 >= 17); 4. Non-aphasic and without severe cognitive disorders, with a Mini-Mental State Examination (MMSE) score (H) greater than 17 (MMSE > 17); 5. Keenness to participate in the trial and provide written informed consent.

Exclusion criteria

Exclusion criteria: Subjects reporting any of the following criteria will be excluded: 1. History or current presence of neuropsychiatric diseases other than depression 2. Candidates at a high risk of attempting suicide (a score of more than 2 points on the third question (Suicide) of the HDRS-17 3. People who, prior to the date of screening: Have taken antidepressants or any psychotropic drugs; Have undergone psychotherapy or Cognitive Behavioral Therapy (CBT); Received any kind of therapeutic interventions related to either Western medical practice or Traditional Chinese Medicine to alleviate the symptoms of MDD. 4. Pregnant, lactating, or planning to become pregnant women; 5. Subjects who have acute inflammation at the planned acupuncture site on the body or any other contraindication to acupuncture; 6. Candidates afraid of needles in general and reluctant to receive acupuncture in particular; 7. Patients with bleeding tendency, severe physical disability or other chronic disorders (e.g: chronic alcoholism, drug abuse); 8. Subject who have already taken part in previous clinical trials where EA treatment was used.

Design outcomes

Primary

MeasureTime frame
17-item Hamilton Depression Scale (HDRS-17);

Secondary

MeasureTime frame
Mini-Mental State Examination (MMSE);Zung Self-Rating Depression Scale (SDS);IL-1ß/IL-18;

Countries

China

Contacts

Public ContactZhenxiang Han

Shanghai Seventh People's Hospital, Shanghai University of TCM

hanxiang798007@163.com+86 17701767768

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026